贵研铂业:定增预案获控股股东同意批复 拟募资12.91亿元加码贵金属材料科创与产业升级

Core Viewpoint - The company plans to raise no more than 1.291 billion yuan through a private placement to enhance its technological innovation platform, upgrade its industry, and supplement working capital, thereby strengthening its precious metals industry chain advantage and promoting high-quality development [1][2]. Fundraising Purpose - The 1.291 billion yuan will be allocated into three main areas: - 484 million yuan for the construction of a technological innovation platform, including 400 million yuan for a national key laboratory for precious metal functional materials and 84 million yuan for an AI laboratory focused on precious metal new materials [1][2]. - 420 million yuan for industrial transformation and upgrading, which includes 170 million yuan for a modern industrial base for the recycling of secondary precious metal resources, 130 million yuan for green recycling of secondary resources, 80 million yuan for deep processing and intelligent upgrading of precious metal alloy functional new materials, and 40 million yuan for the industrialization of platinum anticancer drug raw materials [1][2]. - 387 million yuan to supplement working capital to optimize the capital structure and alleviate financial pressure [1][2]. Project Investment Overview - The total investment for the projects funded by the private placement amounts to approximately 2.531 billion yuan, with the planned fundraising of 1.291 billion yuan [2]. - The projects align closely with the company's main business and comply with national policies on new material industry development, as well as the company's strategic planning [2]. Shareholding Structure - As of the announcement date, Yun Investment Group holds 38.60% of the company's shares, making it the controlling shareholder, with the Yunnan Provincial State-owned Assets Supervision and Administration Commission as the actual controller. The private placement will not result in a change of control of the company [3]. Implementation Requirements - The private placement plan requires approval from the company's shareholders' meeting, as well as review and registration approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [3].